Mayo Clinic study shows AI can help clinicians identify brain tumor risks
recent articles
Fordham University: Thought Leadership Event Will Focus on the Ways in Which Artificial Intelligence Will Impact the Healthcare and Pharmaceutical Industries New York, NY, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Although the benefits of innovative...
iSpecimen and TriMetis Life Sciences: Partnership Aims to Optimize Quality Control and Assurance Through Digital AI Histopathology Services LEXINGTON, Mass., Jan. 23, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or...
From the Lumea Podcast - Ask A Pathologist: In our fifth Ask a Pathologist Podcast episode we had the privilege to interview Dr. Hillel Kahane about his favorite game-changing tools for pathologists. From pre-analytical tools to digital...
Indica Labs: Learn about the exciting new features coming soon in HALO AI 4.0! HALO AI 4.0 Sneak Peek Date: 29 February 2024 Time: 8:00 – 9:00 PST | 11:00 – 12:00 EST | 16:00 – 17:00 GMT Location:...
Cancer mortality in the U.S. has fallen over the past three decades, but increases in common forms of the disease pose a threat to that progress. The number of new cancer cases in the U.S. is expected to top 2 million for the first time in...
Non-cancerous cells called stromal cells, which are found in and around prostate tumors, may be useful in assessing these tumors’ potential to spread, and may even be targets for future prostate cancer treatments, according to a study led by...
